North East and North Cumbria
ICS Formulary
ICS Formulary
12 Ear, nose and oropharynx
12-02-02 Sympathomimetics
| Xylometazoline Otrivine® |
|
First Choice
|
|
 MHRA DSU: Nasal decongestant sprays and drops containing xylometazoline hydrochloride / oxymetazoline hydrochloride: increased risk of rebound congestion, rhinitis medicamentosa, and tachyphylaxis with overuse (April 2026) |
|
Links
- Guidelines for the Management of Adults with Asymptomatic Liver Blood Test Abnormalities
- MHRA DSU: Nasal decongestant sprays and drops containing xylometazoline hydrochloride / oxymetazoline hydrochloride: increased risk of rebound congestion, rhinitis medicamentosa, and tachyphylaxis with overuse (April 2026)
- NTAG: Transanal irrigation (TAI) systems (Peristeen Plus®, Aquaflush®, and QuFora®) for neurogenic bowel dysfunction, chronic constipation and chronic faecal incontinence